New Deal
Kevin Xu
Managing Director at GOLDMAN SACHS ASSET MANAGEMENT
Investor
Hong Kong
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (3)
Key Relationships
Announcement Date
Deal Value
Puyi Biotechnology
Goldman Sachs Asset Management
value n/a
4 dealmakers
Zhenge Biotech
Lyfe Capital
£73m
9 dealmakers
Lepure Biotech
Bayland Capital
6 dealmakers